U.S. markets closed
  • S&P Futures

    4,565.00
    -10.75 (-0.23%)
     
  • Dow Futures

    34,570.00
    -52.00 (-0.15%)
     
  • Nasdaq Futures

    15,940.50
    -48.00 (-0.30%)
     
  • Russell 2000 Futures

    2,195.20
    -10.00 (-0.45%)
     
  • Crude Oil

    66.64
    +0.14 (+0.21%)
     
  • Gold

    1,768.70
    +6.00 (+0.34%)
     
  • Silver

    22.36
    +0.05 (+0.22%)
     
  • EUR/USD

    1.1297
    -0.0009 (-0.08%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • Vix

    27.95
    -3.17 (-10.19%)
     
  • GBP/USD

    1.3286
    -0.0016 (-0.12%)
     
  • USD/JPY

    113.0660
    -0.1430 (-0.13%)
     
  • BTC-USD

    56,570.05
    -704.41 (-1.23%)
     
  • CMC Crypto 200

    1,439.18
    +0.29 (+0.02%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,772.46
    +19.09 (+0.07%)
     

Here's Why Inhibrx Stock Is on the Move Today

·2 min read
Here's Why Inhibrx Stock Is on the Move Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The first clinical trial results for a candidate for the treatment of alpha-1 antitrypsin deficiency look highly encouraging.